Search Results

You are looking at 51 - 60 of 96 items for :

  • "skin cancer" x
Clear All
Full access

Joyce Y. Wong and Vernon K. Sondak

situ . Br J Dermatol 2002 ; 146 : 290 – 294 . 24 Clark GS Pappas-Politis EC Cherpelis BS . Surgical management of melanoma in situ on chronically sun-damaged skin . Cancer Control 2008 ; 15 : 216 – 224 . 25 Quinn MJ Crotty

Full access

Dana E. Rollison, Anna R. Giuliano and Jürgen C. Becker

A Technau K Kurz AK . Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients . Int J Cancer 2009 ; 125 : 356 – 361 . 66. Dworkin AM Tseng SY Allain DC . Merkel cell

Full access

Nina N. Sanford, David J. Sher, Xiaohan Xu, Chul Ahn, Anthony V. D’Amico, Ayal A. Aizer and Brandon A. Mahal

: “Have you ever been told you had cancer?” Among participants who answered yes, the type of cancer was recorded. Those who reported a diagnosis of nonmelanoma skin cancer or skin cancer type unknown were excluded. Participants were also queried regarding

Full access

Zhiyuan Zheng, Ahmedin Jemal, Reginald Tucker-Seeley, Matthew P. Banegas, Xuesong Han, Ashish Rai, Jingxuan Zhao and K. Robin Yabroff

-reported at the time of the survey. We defined cancer survivors as those who reported ever being diagnosed with cancer or any malignancy by a doctor or other health professional. Individuals with nonmelanoma skin cancer only or skin cancer of unknown type were

Full access

Sri Harsha Tella, Anuhya Kommalapati, Apar Kishor Ganti and Alissa S. Marr

Background Cutaneous malignant melanoma (MMel) constitutes approximately 1% of all skin cancers, with an incidence of approximately 22.3 cases/100,000 person-years in the United States. 1 The mortality rate is 2.7 deaths/100,000 persons, with most

Full access

Devon C. Snow and Eric A. Klein

I n 2009 alone, an estimated 192,280 men will be diagnosed with and 27,360 will die of prostate cancer, 1 making it the most common cancer diagnosed in men after skin cancer and the second leading cause of cancer death. Although no cure is

Full access

Tanner M. Johanns, Cole J. Ferguson, Patrick M. Grierson, Sonika Dahiya and George Ansstas

secondary skin cancers and the development of resistance. 43 , 44 In gliomas, previous studies of targeted therapy have mostly been performed using single-agent BRAF inhibitors ( Table 1 ). Thus, the potential benefit of adding an MEK inhibitor (trametinib

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian and Deborah A. Freedman-Cass

: CD004183 . 36. Chang YJ Myung SK Chung ST . Effects of vitamin treatment or supplements with purported antioxidant properties on skin cancer prevention: a meta-analysis of randomized controlled trials . Dermatology 2011 ; 223 : 36 – 44

Full access

Elizabeth A. Rohan, Julie S. Townsend, Temeika L. Fairley and Sherri L. Stewart

been described elsewhere. 11 We excluded respondents who had an unknown cancer history or refused to answer the question (n=5057), or who reported their most recent cancer as nonmelanoma skin cancer (n=16,497). Data Preparation We combined

Full access

James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael Cohen, Anthony Victor D’Amico, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric Mark Horwitz, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Gary R. MacVicar, Arnold W. Malcolm, David Miller, Elizabeth R. Plimack, Julio M. Pow-Sang, Sylvia Richey, Mack Roach III, Eric Rohren, Stan Rosenfeld, Eric J. Small, Sandy Srinivas, Cy Stein, Seth A. Strope, Jonathan Tward, Patrick C. Walsh, Dorothy A. Shead and Maria Ho

Cancer Network, Inc. 2013, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. Overview Other than skin cancer, prostate cancer is the most